🚀 VC round data is live in beta, check it out!

Guardian Pharmacy Service Valuation Multiples

Discover revenue and EBITDA valuation multiples for Guardian Pharmacy Service and similar public comparables like Acadia Healthcare, LifeStance Health, Dr. Soliman Abdul Kader, IKS Health and more.

Guardian Pharmacy Service Overview

About Guardian Pharmacy Service

Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.


Founded

2003

HQ

United States

Employees

3.4K

Financials (LTM)

Revenue: $1B
EBITDA: $117M

EV

$2B

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Guardian Pharmacy Service Financials

Guardian Pharmacy Service reported last 12-month revenue of $1B and EBITDA of $117M.

In the same LTM period, Guardian Pharmacy Service generated $297M in gross profit, $117M in EBITDA, and $55M in net income.

Revenue (LTM)


Guardian Pharmacy Service P&L

In the most recent fiscal year, Guardian Pharmacy Service reported revenue of $1B and EBITDA of $115M.

Guardian Pharmacy Service expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Guardian Pharmacy Service forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$1BXXX$1BXXXXXXXXX
Gross Profit$297MXXX$293MXXXXXXXXX
Gross Margin21%XXX20%XXXXXXXXX
EBITDA$117MXXX$115MXXXXXXXXX
EBITDA Margin8%XXX8%XXXXXXXXX
EBIT Margin6%XXX6%XXXXXXXXX
Net Profit$55MXXX$49MXXXXXXXXX
Net Margin4%XXX3%XXXXXXXXX

Financial data powered by Morningstar, Inc.

Guardian Pharmacy Service Stock Performance

Guardian Pharmacy Service has current market cap of $2B, and enterprise value of $2B.

Market Cap Evolution


Guardian Pharmacy Service's stock price is $37.54.

See Guardian Pharmacy Service trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2B$2B1.6%XXXXXXXXX$0.76

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Guardian Pharmacy Service Valuation Multiples

Guardian Pharmacy Service trades at 1.7x EV/Revenue multiple, and 20.4x EV/EBITDA.

See valuation multiples for Guardian Pharmacy Service and 15K+ public comps

EV / Revenue (LTM)


Guardian Pharmacy Service Financial Valuation Multiples

As of April 18, 2026, Guardian Pharmacy Service has market cap of $2B and EV of $2B.

Equity research analysts estimate Guardian Pharmacy Service's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Guardian Pharmacy Service has a P/E ratio of 43.7x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$2BXXX$2BXXXXXXXXX
EV (current)$2BXXX$2BXXXXXXXXX
EV/Revenue1.7xXXX1.6xXXXXXXXXX
EV/EBITDA20.4xXXX20.7xXXXXXXXXX
EV/EBIT28.1xXXX29.6xXXXXXXXXX
EV/Gross Profit8.0xXXX8.2xXXXXXXXXX
P/E43.7xXXX49.1xXXXXXXXXX
EV/FCF30.0xXXX29.6xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Guardian Pharmacy Service Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Guardian Pharmacy Service Margins & Growth Rates

Guardian Pharmacy Service's revenue in the last 12 month grew by 1%.

Guardian Pharmacy Service's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.

Guardian Pharmacy Service's rule of 40 is 6% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Guardian Pharmacy Service's rule of X is 3% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Guardian Pharmacy Service and other 15K+ public comps

Guardian Pharmacy Service Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth1%XXX(2%)XXXXXXXXX
EBITDA Margin8%XXX8%XXXXXXXXX
EBITDA Growth7%XXX6%XXXXXXXXX
Rule of 40—XXX6%XXXXXXXXX
Bessemer Rule of X—XXX3%XXXXXXXXX
Revenue per Employee—XXX$0.4MXXXXXXXXX
Opex per Employee—XXX$0.1MXXXXXXXXX
Opex to Revenue—XXX15%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Guardian Pharmacy Service Public Comps

See public comps and valuation multiples for other Hospitals & Clinics comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
Guardian Pharmacy ServiceXXXXXXXXXXXXXXXXXX
Acadia HealthcareXXXXXXXXXXXXXXXXXX
LifeStance HealthXXXXXXXXXXXXXXXXXX
Dr. Soliman Abdul KaderXXXXXXXXXXXXXXXXXX
IKS HealthXXXXXXXXXXXXXXXXXX
Topchoice MedicalXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Guardian Pharmacy Service M&A Activity

Guardian Pharmacy Service acquired XXX companies to date.

Last acquisition by Guardian Pharmacy Service was on XXXXXXXX, XXXXX. Guardian Pharmacy Service acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Guardian Pharmacy Service

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Guardian Pharmacy Service Investment Activity

Guardian Pharmacy Service invested in XXX companies to date.

Guardian Pharmacy Service made its latest investment on XXXXXXXX, XXXXX. Guardian Pharmacy Service invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Guardian Pharmacy Service

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Guardian Pharmacy Service

When was Guardian Pharmacy Service founded?Guardian Pharmacy Service was founded in 2003.
Where is Guardian Pharmacy Service headquartered?Guardian Pharmacy Service is headquartered in United States.
How many employees does Guardian Pharmacy Service have?As of today, Guardian Pharmacy Service has over 3K employees.
Who is the CEO of Guardian Pharmacy Service?Guardian Pharmacy Service's CEO is Fred Burke.
Is Guardian Pharmacy Service publicly listed?Yes, Guardian Pharmacy Service is a public company listed on NYSE.
What is the stock symbol of Guardian Pharmacy Service?Guardian Pharmacy Service trades under GRDN ticker.
When did Guardian Pharmacy Service go public?Guardian Pharmacy Service went public in 2024.
Who are competitors of Guardian Pharmacy Service?Guardian Pharmacy Service main competitors are Acadia Healthcare, LifeStance Health, Dr. Soliman Abdul Kader, IKS Health.
What is the current market cap of Guardian Pharmacy Service?Guardian Pharmacy Service's current market cap is $2B.
What is the current revenue of Guardian Pharmacy Service?Guardian Pharmacy Service's last 12 months revenue is $1B.
What is the current revenue growth of Guardian Pharmacy Service?Guardian Pharmacy Service revenue growth (NTM/LTM) is 1%.
What is the current EV/Revenue multiple of Guardian Pharmacy Service?Current revenue multiple of Guardian Pharmacy Service is 1.7x.
Is Guardian Pharmacy Service profitable?Yes, Guardian Pharmacy Service is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Guardian Pharmacy Service?Guardian Pharmacy Service's last 12 months EBITDA is $117M.
What is Guardian Pharmacy Service's EBITDA margin?Guardian Pharmacy Service's last 12 months EBITDA margin is 8%.
What is the current EV/EBITDA multiple of Guardian Pharmacy Service?Current EBITDA multiple of Guardian Pharmacy Service is 20.4x.
What is the current FCF of Guardian Pharmacy Service?Guardian Pharmacy Service's last 12 months FCF is $80M.
What is Guardian Pharmacy Service's FCF margin?Guardian Pharmacy Service's last 12 months FCF margin is 6%.
What is the current EV/FCF multiple of Guardian Pharmacy Service?Current FCF multiple of Guardian Pharmacy Service is 30.0x.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial